Inventor

VAN DEN EYNDE BENOIT

BE32 patents

⚠️ This page may combine multiple inventors who share the name “VAN DEN EYNDE BENOIT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VAN DEN EYNDE BENOIT

LUDWIG INST CANCER RES

Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1

Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof

Isolated nucleic acid molecules which encode MAGE derived nonapeptides

Isolated peptides derived from tumor rejection antigens, and their use

Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors

Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof

Tumor rejection antigen precursors, tumor rejection antigens and uses thereof

Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof

Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof

Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules

Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof

Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof

Methods for diagnosing a disorder by assaying for MAGE-3

Method for screening for cancer using binders for MAGE related peptides and complexes of the peptide and HLA molecules

Isolated nonapeptides presented by HLA molecules, and uses thereof

Method for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3

Mage-A12 antigenic peptides and uses thereof

Isolated nucleic acid molecules which encode GAGE genes and uses thereof

Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-4 and 41 and uses thereof

Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-6 and uses thereof

Methods for treating a disorder by using Mage-3 or Mage-3 related materials

MAGE-C2 antigenic peptides and uses thereof

Isolated proteins MAGE-4 and MAGE-41

Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof

Structurally modified peptides that are resistant to peptidase degradation

Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof

Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor

Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3

Isolated GAGE-7B and 8 proteins

Isolated, truncated nucleic acid which are members of the gage, and uses thereof

Structurally modified peptides that are resistant to peptidase degradation

MA WENBIN

MAGE-C2 antigenic peptides and uses thereof